Regulations.gov document
Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics; Draft…
Notice · FDA-2019-D-5607 · posted Feb 20, 2020
Key facts
| Document ID | FDA-2019-D-5607-0001 |
|---|---|
| Title | Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-5607 |
| Posted | Feb 20, 2020 |
| Federal Register citation | 85 FR 9784 |
| FR document number | 2020-03426 |
| Comment period opens | Feb 20, 2020 |
| Effective date | Feb 20, 2020 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: